In vitro activity of rabeprazole compared with omeprazole in Helicobacter pylori clinical isolates

被引：0
|
作者：
Lopez-Brea, M
Domingo, D
Martinez, M
Escudero, E
Jimenez, S
Alarcon, T
机构：
[1] Hosp Princesa, Madrid, Spain
[2] Hosp Nino Jesus, Madrid, Spain
来源：
GUT | 2001年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
128
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [21] Comparison of five day Helicobacter pylori eradication regimens: Rabeprazole-based and omeprazole-based with and without omeprazole pretreatment
    Adachi, K
    Hashimoto, T
    Ishihara, S
    Fujishiro, H
    Sato, S
    Amano, Y
    Hattori, S
    Kinoshita, Y
    GASTROENTEROLOGY, 2003, 124 (04) : A359 - A360
  • [22] In vitro activity of fluorquinolones and rifampicin in metronidazole and clarithromycin-susceptible or -resistant Helicobacter pylori Spanish clinical isolates
    de Ayala, AP
    Alarcón, T
    Monclus, D
    Abanades, M
    López-Brea, M
    HELICOBACTER, 2005, 10 (05) : 544 - 544
  • [23] In vitro bactericidal activity of amoxicillin against Helicobacter pylori clinical isolates studied by MBC determination and killing curves
    Prieto, N
    Alarcon, T
    Domingo, D
    de la Obra, P
    Serrano, M
    Lopez-Brea, M
    GUT, 2001, 49 : A2 - A2
  • [24] In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China
    Yang, Yanmei
    Bian, Lijun
    Hang, Xudong
    Yan, Caiwang
    Huang, Yan
    Ye, Feng
    Zhang, Guoxin
    Jin, Guangfu
    Bi, Hongkai
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 98 (03)
  • [25] In - Vitro activity of Desmostachya bipinnata (L.) Stapf successive extracts against Helicobacter pylori clinical isolates
    Ibrahim, Nermin H.
    Awaad, Amani S.
    Alnafisah, Rawan A.
    Alqasoumi, Saleh, I
    El-Meligy, Reham M.
    Mahmoud, Amani Z.
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (04) : 535 - 540
  • [26] Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo
    Williams, MP
    Usselmann, B
    Chilton, A
    Sercombe, J
    Nwokolo, CU
    Pounder, RE
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (06) : 775 - 783
  • [27] Characterization of clinical isolates of Helicobacter pylori in Singapore
    Hua, J
    Ng, HC
    Yeoh, KG
    Ho, KY
    Ho, B
    MICROBIOS, 1998, 94 (378) : 71 - 81
  • [28] Tolerance to amoxycillin in clinical isolates of Helicobacter pylori
    Prieto, N
    Alarcón, T
    Domingo, D
    López-Brea, M
    GUT, 1999, 45 : A114 - A114
  • [29] ANTIBACTERIAL ACTIVITY OF PANTOPRAZOLE AND OMEPRAZOLE AGAINST HELICOBACTER-PYLORI
    SUERBAUM, S
    LEYING, H
    KLEMM, K
    OPFERKUCH, W
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (02) : 92 - 93
  • [30] Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori
    Gatta, L
    Perna, F
    Figura, N
    Ricci, C
    Holton, J
    D'Anna, L
    Miglioli, M
    Vaira, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 439 - 442
12345